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Abstract
Background: The introduction of PSA testing in Austria led to a steep increase of the incidence
of prostate cancer. We want to present the course of the number of newly diagnosed cases of
prostate cancer in Austria since 1997, and set these numbers in relation to the total of radical
prostatectomies (with resection of lymph nodes) in the same time period. All numbers were
retrieved from health statistics of Statistics Austria. The report period of cancer cases and of RPE
comprises the years 1997–2004. All calculations were performed for totals as well as for 5-year
age groups (40–89 years of age).
Findings: The number of prostate cancer cases rose from 1997 to 2004 by 35%, while the number
of RPE rose by 94% in the same time period. The proportion of RPE in relation to new cases rose
from 41% in 1997 to 59% in 2004.
Conclusion: A slight decrease of prostate cancer mortality can already be observed in Austria,
but the question of over-treatment still awaits analysis.
Findings
Opportunistic Prostate-Specific-Antigen testing (PSA) of
healthy men started at the beginning of the 1990s and led
to a steep increase of prostate cancer incidence [1-3]. In
Austria data on surgical treatment of prostate cancer are
available since 1997. The purpose of this paper is to
present the correlation between the number of newly
detected cases and the number of radical prostatectomies
with resection of lymph nodes (RPE) by 5 year age group.
Data on the number of newly detected cases and number
of prostatectomies where obtained from Statistics Austria.
The data on radical prostatectomies by age group are
available since 1997 only. The data set covers the age
group 40 to 89 years comprising a population of
1.738,655 men in the year 2000. Since cases are ano-
nymized it is indeterminable whether newly detected
cases are operated in the year of diagnosis or in the follow-
ing year, if ever.
Cases treated by perineal cryosurgery were excluded, due
to the small total number (0 to 2 cases per year).
The number of newly detected cases and of RPE (1997
through 2004) as well as the calculated percentage per
year by 5 year age group are given in table 1. The absolute
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Table 1: Number of newly detected cases of prostate cancer in Austria, and number of radical prostatectomies 1997–2004, as well as proportion of RPE/incidence, and P value 
for linear time trend, totals and 5-year age groups of men aged 40–89.
Age 1997 1998 1999 2000 2001 2002 2003 2004
Nndc RPE Nndc RPE Nndc RPE Nndc RPE Nndc RPE Nndc RPE Nndc RPE Nndc RPE
nn%nn % nn % nn % nn % nn%nn%nn% P - v a l u e
40–44 3 4 >100 5 4 80 5 4 80 16 14 87 18 15 83 17 18 >100 22 17 77 25 25 100 0.338
45–49 26 21 81 40 37 92 44 35 80 74 71 96 85 81 95 95 87 92 125 123 98 109 118 >100 < 0.001
50–54 127 99 78 149 118 79 166 157 95 199 171 86 256 240 94 266 259 97 267 279 >100 254 258 >100 < 0.001
55–59 371 300 61 440 382 87 496 433 87 522 482 92 541 518 96 559 492 88 597 552 92 585 612 >100 < 0.001
60–64 490 369 75 528 359 68 589 454 77 784 688 88 907 798 88 995 884 89 1158 1067 92 1105 980 89 < 0.001
65–69 841 515 61 880 568 65 924 560 61 938 666 71 962 685 71 910 651 72 1065 842 79 1011 789 78 < 0.001
70–74 837 299 36 873 288 33 976 288 30 1042 355 34 1035 390 38 998 370 37 1074 500 47 1001 377 38 < 0.001
75–79 554 34 6 655 31 5 737 38 5 698 40 6 674 42 6 644 26 4 732 119 16 718 36 5 < 0.001
80–84 383 4 1 300 2 <1 316 0 0 333 1 <1 328 2 <1 339 0 0 403 38 9 367 2 <1 < 0.001
85–89 367 0 0 348 0 0 340 0 0 317 1 <1 322 1 <1 258 0 0 284 15 5 325 1 <1 < 0.001
Total 3999 1648 41 4218 1826 43 4593 1969 43 4923 2489 51 5128 2774 54 5081 2791 55 5727 3167 55 5416 3200 59 < 0.001
Nndc ... Number of newly detected cases.
RPE ... Radical Prostatectomy (with resection of lymph nodes).
P-value ... P value for linear time trend.BMC Research Notes 2008, 1:48 http://www.biomedcentral.com/1756-0500/1/48
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number of prostate cancer cases rose from 3999 in 1997
to 5416 in 2004 (+35.4%, all age groups). The absolute
number of RPE rose from 1648 in 1997 to 3200 in 2004
(+94.2%, all age groups). The percentage of RPE in rela-
tion to the number of newly detected cases rises from 41%
in 1997 to 59% in 2004 (all age groups). The increase of
this percentage is observed in all age groups younger than
70 years but not in older age groups, the linear trend over
time is significant for all age groups and for totals, except
for age group 40–44 years.
The increase of the incidence of prostate cancer is well
documented for Austria [1,2], however the absolute num-
bers are for the first time set in relation to the number of
RPE nationwide. Within 8 years, the total number of RPE
increased by 94.2%, thus nearly doubled, with the
increase mainly occurring in the age group 55–69 years.
Starting at age 70 years the percentage of RPE remains
more or less stable on a substantially lower level.
The number of RPE we used in our calculations represents
the official hospital discharge statistics of Austria compris-
ing of the collected data of all hospitals (including private
hospitals), but excludes a very small number of self-pay
patients. Thus our results negligibly may underestimate
the relation of RPE to the number of newly detected cases.
A further limitation of our analyses is caused by legal con-
strains: due to data protection laws we are limited to the
use of depersonalized data.
The increase of RPE in Austria can be explained by at least
three factors: a) operation technique meliorated signifi-
cantly, now is a standard procedure, perioperative mortal-
ity is low and the risk of postoperative morbidity such as
incontinence and erectile dysfunction decreased in Aus-
tria [4,5], consequently acceptance of RPE in patients
increased. b) By the introduction of PSA testing the target
group of prostate cancer screening shifted towards
younger age groups, meaning that carcinoma more fre-
quently is sought in younger men [3]. c) Because of the
slow progression of most cases, RPE only makes sense
when health status permits RPE and patients have a life
expectancy of at least 10 years [6].
The high percentage of RPE in men younger than 70 years
surely also is influenced by the fact that counselling
(towards RPE or radiation therapy) in Austria is per-
formed by urologists. In this context, it is worth mention-
ing, that the primary intention of this manuscript is to
provide the data which can serve as a basis for a construc-
tive discussion about counselling and the provision of the
most adequate therapeutic regimes.
The reason for the more or less stable percentage in men
aged 70 years or older may lie in the fact that therapy of
prostate cancer in these patients more often relies on
watchful waiting, active surveillance, external beam radia-
tion, brachytherapy or hormonal treatment. Detailed data
for these therapies are not available.
In conclusion, currently 59% of prostate cancer cases
detected are treated by RPE, a percentage steadily rising
from 1997 on. On one hand, the dramatic increase of RPE
already leads to a slight reduction of prostate cancer mor-
tality in Austria [3,7], on the other hand the question of
over-testing and over-treatment, and added morbidity
remains unanswered and analyses are still pending for
Austria.
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